iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionStephens Inc /ar/
Latest Disclosed Ownership7,454 shares
Latest Disclosed Value $ 1,258,626
Stephens Inc /ar/ reports 2.11% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Stephens Inc /ar/ filed a 13F-HR form disclosing ownership of 7,454 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,258,626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 7,300 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 2.11% during the quarter. The current value of the position is $976,847 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,454 154 2.11 1,259 2.11 0.0157
2026-02-05 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,300 1,988 37.42 1,232 60.84 0.0153
2025-10-27 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,312 0 0.00 767 13.99 0.0098
2025-07-29 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,312 471 9.73 672 8.56 0.0092
2025-05-01 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,841 0 0.00 619 -3.13 0.0091
2025-01-28 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,841 -85 -1.73 640 -10.88 0.0090
2024-10-28 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,926 -33 -0.67 717 5.44 0.0102
2024-08-06 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,959 -1,745 -26.03 681 -26.01 0.0104
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,704 134 2.04 920 3.03 0.0143
2024-02-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,570 -641 -8.89 893 1.25 0.0154
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,211 -188 -2.54 882 -6.18 0.0169
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,399 -302 -3.92 939 -5.53 0.0169
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,701 -434 -5.33 995 -6.93 0.0191
2023-02-14 2022-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 8,135 1,649 25.42 1,068 40.71 0.0219
2023-01-25 2022-12-31 13F ISHARES TR SHARES BIOTECH 464287556 8,135 1,649 1 0.0219
2022-11-02 2022-09-30 13F ISHARES TR SHARES BIOTECH 464287556 6,486 -862 -11.73 759 -12.15 0.0162
2022-08-03 2022-06-30 13F ISHARES TR SHARES BIOTECH 464287556 7,348 -1,166 -13.70 864 -22.09 0.0174
2022-05-04 2022-03-31 13F ISHARES TR SHARES BIOTECH 464287556 8,514 -12,708 -59.88 1,109 -65.76 0.0181
2022-03-07 2021-12-31 13F ISHARES TR SHARES BIOTECH 464287556 21,222 -6,017 -22.09 3,239 -26.45 0.0490
2021-10-27 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 27,239 -1,304 -4.57 4,404 -5.72 0.0681
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,543 -17,346 -37.80 4,671 -32.39 0.0699
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45,889 2,066 4.71 6,909 4.07 0.1135
2021-02-10 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 43,823 2,826 6.89 6,639 19.60 0.1191
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 40,997 -295 -0.71 5,551 -1.65 0.1093
2020-08-24 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 41,292 19,307 87.82 5,644 138.24 0.1213
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 21,985 2,268 11.50 2,369 -0.29 0.0631
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 19,717 2,095 11.89 2,376 35.54 0.0498
2019-10-18 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 17,622 -150 -0.84 1,753 -9.59 0.0386
2019-08-01 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 17,772 1,131 6.80 1,939 4.19 0.0439
2019-05-03 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 16,641 -1,252 -7.00 1,861 7.88 0.0441
2019-02-11 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 17,893 -2,245 -11.15 1,725 -29.76 0.0489
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,138 5,917 41.61 2,456 57.23 0.0611
2018-08-10 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 14,221 -233 -1.61 1,562 1.23 0.0472
2018-05-03 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 14,454 1,156 8.69 1,543 8.66 0.0575
2018-02-05 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,298 9,286 231.46 1,420 6.13 0.0531
2017-11-08 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 4,012 902 29.00 1,338 38.80 0.0483
2017-08-10 2017-06-30 13F ISHARES TR NASDQ BIOTEC E 464287556 3,110 382 14.00 964 20.50 0.0331
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC E 464287556 2,728 1,166 74.65 800 92.77 0.0291
2017-02-09 2016-12-31 13F ISHARES TR NASDQ BIOTEC E 464287556 1,562 -7,000 -81.76 415 -83.25 0.0169
2016-11-30 2016-09-30 13F/A-2 ISHARES TR NASDQ BIOTEC E 464287556 8,562 1,570 22.45 2,478 37.74 0.1085
2016-11-10 2016-09-30 13F ISHARES TR NASDQ BIOTEC E 464287556 8,562 2,478
2016-08-05 2016-06-30 13F ISHARES TR NASDQ BIOTEC E 464287556 6,992 5,907 544.42 1,799 535.69 0.0802
2016-05-05 2016-03-31 13F ISHARES TR NASDQ BIOTEC E 464287556 1,085 -509 -31.93 283 -47.50 0.0139
2016-02-10 2015-12-31 13F ISHARES TR NASDQ BIOTEC E 464287556 1,594 -1,064 -40.03 539 -33.13 0.0270
2015-11-03 2015-09-30 13F ISHARES TR NASDQ BIOTEC E 464287556 2,658 -29 -1.08 806 -18.67 0.0420
2015-07-29 2015-06-30 13F ISHARES TR NASDQ BIOTEC E 464287556 2,687 742 38.15 991 48.35 0.0450
2015-05-06 2015-03-31 13F ISHARES TR NASDQ BIOTEC E 464287556 1,945 5 0.26 668 13.61 0.0304
2015-02-12 2014-12-31 13F ISHARES TR NASDQ BIOTEC E 464287556 1,940 517 36.33 588 51.16 0.0278
2014-11-14 2014-09-30 13F ISHARES TR NASDQ BIOTEC E 464287556 1,423 -568 -28.53 389 -24.02 0.0192
2014-08-15 2014-06-30 13F ISHARES NASDQ BIOTEC E 464287556 1,991 -940 -32.07 512 -26.12 0.0258
2014-05-13 2014-03-31 13F ISHARES NASDQ BIOTEC E 464287556 2,931 -40 -1.35 693 2.67 0.0378
2014-02-14 2013-12-31 13F ISHARES NASDQ BIOTEC E 464287556 2,971 -126 -4.07 675 4.01 0.0335
2013-11-06 2013-09-30 13F ISHARES NASDQ BIOTEC E 464287556 3,097 180 6.17 649 28.01 0.0350
2013-08-12 2013-06-30 13F ISHARES TR NASDQ BIO INDX 464287556 2,917 2,917 507 0.0283
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.